International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma.
Saved in:
| Title: | International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma. |
|---|---|
| Authors: | Zarba M; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada., O'Sullivan D; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada., Maj D; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada., Cheung WY; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada., Ludwig L; Department of Medical Oncology, IPSEN, Edmonton, AB, Canada., Wells C; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada., Ferrier E; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada., El Hajj Chehade R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States., Donskov F; Department of Medical Oncology, University Hospital of Southern Denmark, Esbjerg, Denmark., Eid M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States., Pal SK; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, Canada., Beuselinck B; Department of Medical Oncology, UZ Leuven, Leuven, Belgium., McKay RR; Department of Medical Oncology, UC San Diego School of Medicine, San Diego, CA, United States., Wood L; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada., Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Suárez C; Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Takemura K; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Duran I; Hospital Universitario Marqués de Valdecilla, IDIVAL Santander, Santander, Spain., Choueiri TK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States., Heng DY; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada.; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada. |
| Source: | Frontiers in oncology [Front Oncol] 2026 May 04; Vol. 16, pp. 1827686. Date of Electronic Publication: 2026 May 04 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42158436 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zarba+M%22">Zarba M</searchLink>; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22O'Sullivan+D%22">O'Sullivan D</searchLink>; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Maj+D%22">Maj D</searchLink>; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Cheung+WY%22">Cheung WY</searchLink>; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Ludwig+L%22">Ludwig L</searchLink>; Department of Medical Oncology, IPSEN, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Wells+C%22">Wells C</searchLink>; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Ferrier+E%22">Ferrier E</searchLink>; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22El+Hajj+Chehade+R%22">El Hajj Chehade R</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Donskov+F%22">Donskov F</searchLink>; Department of Medical Oncology, University Hospital of Southern Denmark, Esbjerg, Denmark.<br /><searchLink fieldCode="AU" term="%22Eid+M%22">Eid M</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Pal+SK%22">Pal SK</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, Canada.<br /><searchLink fieldCode="AU" term="%22Beuselinck+B%22">Beuselinck B</searchLink>; Department of Medical Oncology, UZ Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22McKay+RR%22">McKay RR</searchLink>; Department of Medical Oncology, UC San Diego School of Medicine, San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Wood+L%22">Wood L</searchLink>; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Lee+JL%22">Lee JL</searchLink>; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Suárez+C%22">Suárez C</searchLink>; Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Takemura+K%22">Takemura K</searchLink>; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Duran+I%22">Duran I</searchLink>; Hospital Universitario Marqués de Valdecilla, IDIVAL Santander, Santander, Spain.<br /><searchLink fieldCode="AU" term="%22Choueiri+TK%22">Choueiri TK</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Heng+DY%22">Heng DY</searchLink>; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada.; Cumming School of Medicine, Department of Oncology, University of Calgary, Calgary, AB, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 May 04; Vol. 16, pp. 1827686. <i>Date of Electronic Publication: </i>2026 May 04 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42158436 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2026.1827686 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1827686 Titles: – TitleFull: International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zarba M – PersonEntity: Name: NameFull: O'Sullivan D – PersonEntity: Name: NameFull: Maj D – PersonEntity: Name: NameFull: Cheung WY – PersonEntity: Name: NameFull: Ludwig L – PersonEntity: Name: NameFull: Wells C – PersonEntity: Name: NameFull: Ferrier E – PersonEntity: Name: NameFull: El Hajj Chehade R – PersonEntity: Name: NameFull: Donskov F – PersonEntity: Name: NameFull: Eid M – PersonEntity: Name: NameFull: Pal SK – PersonEntity: Name: NameFull: Beuselinck B – PersonEntity: Name: NameFull: McKay RR – PersonEntity: Name: NameFull: Wood L – PersonEntity: Name: NameFull: Lee JL – PersonEntity: Name: NameFull: Suárez C – PersonEntity: Name: NameFull: Takemura K – PersonEntity: Name: NameFull: Duran I – PersonEntity: Name: NameFull: Choueiri TK – PersonEntity: Name: NameFull: Heng DY IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 05 Text: 2026 May 04 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
